Buch, Englisch, Band 465, 496 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 1980 g
Past Achievements and Future Challenges
Buch, Englisch, Band 465, 496 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 1980 g
Reihe: Advances in Experimental Medicine and Biology
ISBN: 978-0-306-46191-0
Verlag: Springer US
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Gentherapie
- Naturwissenschaften Biowissenschaften Molekularbiologie
Weitere Infos & Material
The Clinical Problem.- Management Problems in Oncology.- Vectors.- Adenoviral Vectors.- Retrovirus Vectors.- Targetable Gene Delivery Vectors.- Human ?-fetoprotein Transcriptional Regulatory Sequences.- Tumor-Targeted Salmonella.- Mutant Adenoviruses Selectively Replication-Competent in Tumor Cells.- Polyoma and Papilloma Virus Vectors For Cancer Gene Therapy.- Cochleates.- The Use Of Skeletal Muscle To Express Genes For The Treatment Of Cancer.- Cell Cycle Control.- Adhesion Molecules in Cancer Biology.- Cell Cycle Control.- Apoptosis.- Killer/DR5, A Novel DNA-Damage Inducible Death Receptor Gene, Links the p53-Tumor Suppressor to Caspase Activation and Apoptotic Death.- Apoptin®.- Adenovirus-Mediated Herpes Simplex Thymidine Kinase Gene Therapy For Brain Tumors.- Development of Clinical Trial of E1A Gene Therapy Targeting HER-2/neu-overexpressing Breast and Ovarian Cancer.- Tumout Suppressor Genes.- Pre-clinical Studies with Tumor Suppressor Genes.- Gene Therapy for Liver Tumours.- Adenovirus-mediated Transfer of a p53 Gene in Ovarian Cancer.- Other Systems.- Eliciting Hyperacute Rejection as a Tumor Killing Strategy.- Innate Immune Therapy For Cancer.- Mda-7, A Novel Melanoma Differentiation Associated Gene with Promise for Cancer Gene Therapy.- Antisense and Ribozymes.- Antisense IGF and Antisense IGF-IR Therapy of Malignancy.- Sensitization of Tumors to Chemotherapy Through Gene Therapy.- Design and Testing of Ribozymes for Cancer Gene Therapy.- Ribozymes.- The Approach of Triple Helix Formation in Control of Gene Expression and The Treatment of Tumors Expressing IGF-I.- Immuno-Modulation.- Dendritic Cell-based Immunization for Cancer Therapy.- Hybrid Cell Vaccination for Cancer Immunotherapy.- Modulation of the Immune Response Through 4-1BB.- Heat Shock Proteinsin Cancer Therapy.- Bi-Specific Antibodies in Cancer Therapy.- B7.1 and Cytokines.- Intralesional Vaccinia/GM-CSF Recombinant Virus in the Treatment of Metastatic Melanoma.- Suicidal Genes.- Approaches to Gene-Directed Enzyme Prodrug Therapy (GDEPT).- Suicide Gene Therapy.- Adenoviruses as Gene Delivery Vectors.- Angiogenesis Control.- Evaluation of an Inhibitor of DNA Methylation, 5-aza-2?-Deoxycytidine, for The Treatment of Lung Cancer and the Future Role of Gene Therapy.- Vascular Endothelial Growth Factor as a Target for Cancer Gene Therapy.- Adeno-Associated Virus and Other Potential Vectors for Angiostatin and Endostatin Gene Therapy.- Matrix Metallo Proteinase.- Potential Applications of Tissue Inhibitor of Metalloproteinase (TIMP) Overexpression For Cancer Gene Therapy.